{{Rsnum
|rsid=2857656
|Gene=CCL2
|Chromosome=17
|position=34254988
|Orientation=plus
|GMAF=0.4513
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CCL2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 43.5 | 56.5
| HCB | 31.1 | 53.3 | 15.6
| JPT | 40.9 | 47.7 | 11.4
| YRI | 19.7 | 50.8 | 29.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.1 | 53.3 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19506371
|Title=Single Nucleotide Polymorphisms in Monocyte Chemoattractant Protein-1 and Its Receptor Act Synergistically to Increase the Risk of Carotid Atherosclerosis
|OA=1
}}

{{PMID Auto
|PMID=22384203
|Title=MCP1 SNPs and Pulmonary Tuberculosis in Cohorts from West Africa, the USA and Argentina: Lack of Association or Epistasis with IL12B Polymorphisms
|OA=1
}}
{{PMID|18940815|OA=1
}} MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa.

{{PMID|20111728|OA=1
}} Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.

{{PMID Auto
|PMID=23198952
|Title=Association of CXCL1 promoter polymorphism with ischaemic stroke in Korean population.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}